Bevacizumab/Ixabepilone (Bms-247550) Combination Produces Synergistic Antitumor Efficacy In Multiple Tumor Models In Vivo And Is Superior To Bevacizumab/Paclitaxel Combination.
CLINICAL CANCER RESEARCH（2005）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要